Collagen Market

How big is Collagen Market in 2026?

Sales in the Collagen Market are projected to grow at 5.7% CAGR through 2036. Market size rises from USD 5.9 billion in 2025 to a projected USD 6.2 billion in 2026 and is expected to reach USD 10.8 billion by 2036.

Collagen is processed into peptides, gelatin, native material, and recombinant grades which are used in nutraceuticals, food products, cosmetics, personal care, pharmaceutical, and biomedical applications. Increasing protein consumption is giving collagen powders, gummies, and drinks a familiar place in daily supplement routine. In July 2025, the International Food Information Council reported that 70% of Americans were trying to consume more protein[1]. FMI believes that soluble peptide grades mix easily in several products, due to which manufacturers are widening their collagen portfolio. However, product claims, source documents, and final formulation testing remain important before collagen products are introduced in the market.

Germany collagen market is projected to witness 7.4% CAGR, while Japan collagen market is estimated to expand at 6.7% CAGR, during 2026 to 2036. In April 2026, the German Federal Institute for Risk Assessment reported that 43% of respondents felt they were not sufficiently supplied through regular food, which often triggered supplement use[2]. High use of supplements and availability across pharmacy, specialty, and online stores is supporting collagen demand in Germany. Japan also has wide consumption of beauty foods, beverages, and functional products. However, Foods with Function Claims requires safety and function evidence, whereas FOSHU products need government permission [6]. Due to these different routes, product release can take more time in Japan. Presence of established supplement and beauty product industries is likely to fuel collagen sales in both countries over the forecast period.

Key Takeaways

• Powders, gummies, tablets, and drinks are increasing the use of collagen in daily nutraceutical products.
• Nutraceuticals are estimated to hold 24.6% of form revenue in 2026, owing to flexible dosing across several supplement formats.
• Animal-based collagen is projected to hold 41.1% of collagen type demand in 2026, supported by established bovine, porcine, and marine processing routes.
• Collagen hydrolysate peptides are expected to represent 66.7% of ingredient type demand in 2026 as soluble grades support measured dosing.
• Germany is forecast at 7.4% CAGR and Japan at 6.7% CAGR, with supplement use and claim systems shaping the difference.
• Notable companies in the Collagen Market include Darling Ingredients Inc., GELITA AG, Nitta Gelatin Inc., Symrise AG, dsm-firmenich, PB Leiner, Lapi Gelatine S.p.A., and CollPlant Biotechnologies Ltd.

Analyst Perspective

"Growing use of collagen in powders, gummies, drinks, and beauty products will maintain the product demand. Recombinant collagen and biomedical materials will create new avenues for collagen manufacturers."

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the collagen market segmented?

The Collagen Market is segmented by four primary commercial axes and region: form, collagen type, ingredient type, sales channel, and region. In 2026, nutraceuticals is estimated at 24.6% of form revenue, animal-based collagen at 41.1% of collagen type demand, collagen hydrolysate peptides at 66.7% of ingredient type demand, and business-to-business sales at 35.0% of sales channel demand.

Form covers nutraceuticals, food and beverage, powder, capsules, cosmetics and personal care, tablets and pills, liquid, and gummies.
Collagen type covers animal-based collagen, type I, type II, type III, marine collagen, porcine collagen, recombinant collagen, and alternative and recombinant collagen.
Ingredient type covers collagen hydrolysate peptides, gelatin, native collagen, and recombinant and fermentation-derived collagen.
Sales channel covers business-to-business sales, store-based retail, online retail, drugstores and pharmacies, hypermarkets and supermarkets, specialty stores, and health and wellness stores.

Why does nutraceuticals hold a notable share of form demand?

Nutraceuticals is estimated to hold 24.6% of form revenue in 2026, supported by flexible dosing in daily supplement formats.

Nutraceuticals has become one of the highly used forms of collagen owing to its increasing application in powders, gummies, tablets, capsules, and ready-to-mix drinks. Collagen peptides can be added in different serving formats and this allows manufacturers to introduce more than one finished product by using a similar collagen ingredient. GELITA offers collagen peptides for beauty, mobility, active nutrition, supplement, and functional food products. Apart from that, powdered supplements and gummies are easy to include in regular consumption. Increasing preference for convenient nutrition products is expected to boost the demand for nutraceutical collagen over the forecast years.

• Nutraceuticals is projected at 24.6% of form revenue in 2026 as flexible dosing supports repeat-use supplement formats.
• The same peptide ingredient can be extended across powders, gummies, and tablets when taste and serving level remains suitable.

What keeps animal-based collagen preferred within collagen type demand?

Animal-based collagen is projected at 41.1% of collagen type demand in 2026, supported by established sourcing routes.

Animal-based collagen is one of the widely used collagen types as it is obtained from established bovine, porcine, poultry, and marine sources. Animal collagen can be processed into collagen peptides, gelatin, native collagen, and biomedical materials. Nitta Gelatin supplies collagen peptides and gelatin ingredients for food, supplement, pharmaceutical, and other applications. Availability of raw material and established processing facilities is supporting the production of animal-based collagen at commercial scale. However, source origin affects labeling, religious suitability, traceability, and product claims. Owing to wider availability and several end uses, animal-based collagen is expected to retain a prominent share in collagen market during the forecast period.

• In 2026, animal-based collagen is expected at 41.1% of collagen type demand because established processing supports commercial supply.
• Bovine, porcine, poultry, and marine origin changes labeling, religious suitability, and the claims available to a finished product.

How do collagen hydrolysate peptides meet changing ingredient type needs?

Collagen hydrolysate peptides are expected to represent 66.7% of ingredient type demand in 2026, owing to soluble dose-flexible formats.

Collagen hydrolysate peptides are produced by breaking collagen into smaller peptide chains. These smaller peptides are easy to mix with water and are used in powders, drinks, gummies, tablets, protein blends, and functional food products. Collagen hydrolysate peptides also provide flexibility in serving level, due to which the same ingredient can be used across several product formats. Higher concentration can change the taste and mixing property of the finished product, therefore manufacturers test the selected peptide in the final formula. Increasing demand for soluble and dose-flexible collagen ingredients is anticipated to drive the collagen hydrolysate peptides segment.

• By ingredient type, collagen hydrolysate peptides are estimated at 66.7% in 2026 as solubility supports measured dosing.
• Higher serving levels can alter flavor and dispersion, due to which the selected peptide must be checked in the final product.

Why are business-to-business sales used for ingredient procurement?

Business-to-business sales are forecast at 35.0% of sales channel demand in 2026, linked to direct ingredient procurement.

Business-to-business sales holds a notable share as collagen generally moves first to food, supplement, beauty, pharmaceutical, and biomedical manufacturers. These manufacturers purchase collagen peptides, gelatin, native collagen, or premix material according to product source, dosage form, and application. dsm-firmenich provides premix support where collagen can be blended with vitamins and other active ingredients. Large ingredient orders and continuous production of finished collagen products are supporting direct sales. Retail channels, on the other hand, mainly carry powders, gummies, drinks, capsules, tablets, and beauty products for final consumers.

• Business to business sales are projected at 35.0% of sales channel demand in 2026 because ingredient approval precedes retail conversion.
• Large ingredient orders and regular manufacturing schedules continue to keep collagen movement strong through direct sales.

What are the drivers, restraints, and opportunities in the collagen market?

In the collagen market, the key driver is daily protein use, the key restraint is claims control, and the key opportunity is recombinant collagen.

• Driver: Daily protein purchasing gives collagen repeat-use demand in powders, gummies, and drinks built around familiar supplement routines.
• Restraint: Claims rules can delay release even with a technically finished collagen formula because benefit language still needs support.
• Opportunity: Recombinant collagen can serve products that require a non-animal source or a defined protein sequence.

Supplement Use Supports Daily Collagen Formats

Broad dietary-supplement use is supporting demand for convenient collagen formats. In May 2026, the CDC’s National Center for Health Statistics reported that 60.2% of U.S. adults used at least one dietary supplement in the previous 30 days and 38.7% used two or more, based on NHANES August 2021-August 2023 data [11]. Consumers purchasing protein products are already familiar with powders, measured servings, gummies, and ready-to-drink products. This established supplement routine gives collagen brands several familiar delivery formats for daily use. Apart from nutrition, collagen is also used in beauty and mobility products. High adult supplement participation is expected to support collagen ingredient sales during the forecast period.

Evidence Standards Limit Broad Product Claims

A key restraint for collagen products is the need to match commercial claims with consistent evidence. A 2026 systematic review published by Frontiers found only six eligible studies for tendon and ligament injuries and described the evidence as sparse, heterogeneous, and low certainty [12]. This creates a practical barrier for products promoted with broad beauty, mobility, or regenerative benefits. Companies may need stronger formulation-specific studies, carefully limited wording, and additional review of product packaging before launch. Evidence costs and restrictions on unsupported health language may therefore slow product introduction and promotion.

Recombinant Production Expands Commercial Scale

Recombinant collagen is manufactured through engineered expression systems rather than extraction from bovine, porcine, poultry, or marine material. A 2026 review indexed by the Directory of Open Access Journals reported recombinant type III collagen yields of 3.02 g/L in Escherichia coli and 10.3 g/L in Pichia pastoris [13]. These reported yields show how fermentation platforms are moving toward more scalable production for skincare, wound dressings, tissue engineering, and other biomedical uses. Manufacturers can use defined sequences to develop personal care and regenerative materials with controlled specifications. Continued improvement in expression and purification is expected to create new opportunities for recombinant collagen suppliers.

Which country CAGRs are profiled in the collagen market?

Country	CAGR
USA	6.2%
UK	5.1%
Germany	7.4%
Japan	6.7%
South Korea	4.0%
Australia	4.4%
Netherlands	5.7%

How do country-level CAGRs compare in the collagen market?

Collagen demand differs from country to country depending upon supplement consumption, beauty product use, retail availability, and claims regulations. The USA, UK, and Germany have developed pharmacy, specialty store, mass retail, and online channels for collagen powders, gummies, capsules, tablets, and liquids. Japan and South Korea have established functional food and beauty nutrition industries; however, approved ingredients and function claims requires closer review. Australia provides general supplement as well as listed-medicine routes for selected products. The Netherlands has wide online availability, while health claims on collagen websites are actively inspected. These factors are expected to keep the growth rate of each country different throughout the forecast period.

• USA collagen products reach consumers through supplement stores, mass retail, pharmacies, online platforms, and private-label brands.
• UK pharmacies and online stores are widening access to collagen, while medicinal claims remain restricted for food supplements.
• High supplement use and broad pharmacy or online availability are supporting collagen demand in Germany.
• Japan has established beauty and functional-food demand, but the selected claim route decides the evidence required before sale.
• South Korean collagen peptide products remain influenced by functional ingredient re-evaluation after market entry.
• Australia provides general supplement and listed-medicine options depending on the product composition and claims.
• Online retail is widening collagen availability in the Netherlands, whereas active claim inspection limits prohibited promotion.

Full report country CAGRs cover: North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa.

Country-wise Analysis

• The USA collagen market is estimated to expand at 6.2% CAGR from 2026 to 2036. Collagen powders, gummies, tablets, capsules, liquids, and ready-to-mix products are widely available through supplement stores, pharmacies, mass retail, online platforms, and private-label brands. In December 2025, the U.S. Food and Drug Administration allowed enforcement discretion for repeating the DSHEA disclaimer on every label panel, while the disclaimer is still required with qualifying claims [3]. The change reduces repeated label wording, but collagen companies remain responsible for beauty, mobility, and other benefit statements. Increasing retail availability is expected to boost collagen sales in the USA, whereas unsupported claims can affect product introduction.
• The UK collagen market is projected to rise at 5.1% CAGR during 2026 to 2036. Collagen is sold in powder, capsule, gummy, liquid, tablet, and beauty nutrition formats across pharmacy and online channels. In June 2026, the Food Standards Agency stated that food supplements can be sold in these dosage forms but should not be promoted as products that prevent, treat, or cure a medical condition[5]. Therefore, collagen brands can use supplement and general wellness positioning, while medicinal language may shift the product into another regulatory area. Increasing online sales and growing preference for beauty supplements is likely to support the demand for collagen in the UK.
• Germany collagen demand is anticipated to grow at 7.4% CAGR over the forecast period. In April 2026, the German Federal Institute for Risk Assessment reported that 77% of respondents, or 825 of 1,071 people, used food supplements [14]. Germany therefore has a large number of consumers already purchasing powders, tablets, capsules, liquids, and other supplement products. Pharmacy, specialty stores, and online channels are widening the availability of collagen. Apart from that, official communication continues to separate food supplements from medicines. High supplement use and wider retail reach is expected to propel collagen market growth in Germany.
• Japan collagen demand is projected to grow at 6.7% CAGR from 2026 to 2036. Collagen has established application in beauty foods, powders, beverages, gummies, and functional products. The Consumer Affairs Agency separates Foods with Function Claims from Foods for Specified Health Uses, and both routes carries different evidence and permission requirements[6]. Manufacturers deciding the route before formulation can select the collagen grade, serving level, and supporting evidence according to the planned claim. However, change in function wording at a later stage can increase the product release time. Presence of developed beauty and functional food industries is anticipated to fuel collagen demand in Japan.
• South Korea collagen demand is estimated to expand at 4.0% CAGR during the assessment period. Collagen peptide is used in ingestible beauty and health-functional-food products. In January 2025, the Ministry of Food and Drug Safety published re-evaluation results for functional ingredients including collagen peptide[7]. Revised conditions can require manufacturers to update ingredient records or statements used for a finished product. Thus, companies supplying stable peptide grades and current evidence are expected to remain better placed in these programs. Increasing consumer preference for beauty nutrition is supporting collagen demand, however functional ingredient re-evaluation may slow changes in product formulation.
• Australia collagen sales are forecast to expand at 4.4% CAGR during 2026 to 2036. Collagen is sold in ordinary supplement formats and can also be included in listed medicines when composition and claims meet the required route. On January 31, 2025, the Therapeutic Goods Administration recorded an active listed medicine containing hydrolysed collagen under ARTG 477269[8]. This shows that collagen can move beyond general food supplement supply with an appropriate product file. Manufacturers selecting dosage form and claim route at the beginning can avoid later changes in label and documentation. Availability of more than one product route is creating growth opportunities for collagen market in Australia.
• The Netherlands collagen market is forecast to rise at 5.7% CAGR through 2036. Online stores provide wide availability of collagen powders, capsules, gummies, liquids, and beauty supplements. In 2025, the Netherlands Food and Consumer Product Safety Authority inspected 30 collagen supplement websites and found that 25 did not meet claims requirements[9]. This indicates that online availability does not protect sellers using prohibited health or medical claims. Sellers may be required to correct the claim and can face further action when the wording remains unchanged. Growing e-commerce will support collagen sales, however active inspection is likely to restrict exaggerated promotion in the Netherlands.

Who are the notable companies in the collagen market?

A few notable companies include Darling Ingredients Inc., GELITA AG, Nitta Gelatin Inc., Symrise AG, dsm-firmenich, PB Leiner, Lapi Gelatine S.p.A., and CollPlant Biotechnologies Ltd. among a broader supplier base.

Some of the prominent players in collagen market are Darling Ingredients Inc., GELITA AG, Nitta Gelatin Inc., Symrise AG, dsm-firmenich, PB Leiner, Lapi Gelatine S.p.A., and CollPlant Biotechnologies Ltd. In December 2025, Darling Ingredients and Tessenderlo Group signed a definitive agreement to combine Rousselot and PB Leiner, subject to regulatory approval [10]. The proposed company was stated to have around 200,000 metric tons of collagen and gelatin capacity across 22 facilities[10]. Established collagen companies are expanding peptide, gelatin, formulation, and biomedical product portfolios in order to cater to the growing demand. Apart from that, recombinant collagen companies are developing bioinks and defined collagen materials. Increasing product development and combination of large processing businesses is expected to intensify competition in collagen market.

• Conventional collagen and gelatin suppliers: Darling Ingredients Inc. through Rousselot, GELITA AG, Nitta Gelatin Inc., PB Leiner, and Lapi Gelatine S.p.A.
• Formulation and medical-material platforms: Symrise AG and dsm-firmenich support nutrition, beauty, premix, or medical collagen applications.
• Recombinant collagen platform: CollPlant Biotechnologies Ltd. develops recombinant human collagen as an alternative to native collagen materials for bioprinting programs.

Competitive Benchmarking: Collagen Market

Company	Collagen Portfolio	Application Support	Technology Depth	Geographic Reach
Darling Ingredients Inc.	High	High	High	High
GELITA AG	High	High	High	High
Nitta Gelatin Inc.	High	High	High	High
Symrise AG	Medium	High	Medium	High
dsm-firmenich	Medium	High	High	High
PB Leiner	High	High	High	High
Lapi Gelatine S.p.A.	Medium	Medium	Medium	High
CollPlant Biotechnologies Ltd.	Low	Medium	High	Medium

High represents wider current product and geographic coverage. Medium represents a specialized product portfolio or limited reach, while Low represents lower documented breadth. The table describes the present activities of the companies and does not indicate market share, product quality, or company ranking.

Key Developments in the Collagen Market

• In March 2026, Symrise established a Care & Wellness division that combines cosmetic ingredients with health actives and biotics.
• In March 2026, dsm-firmenich completed a USD 10 million modernization of its Schenectady premix facility for human food, dietary supplements, and infant formula premix blends.
• In March 2026, GELITA and Black Drop signed a research and development agreement for GelMA bioinks used in biomedical applications.
• In February 2026, CollPlant launched BioFlex as a ready-to-print recombinant human collagen kit for DLP bioprinting applications.

Key Players in the Collagen Market

Integrated Collagen, Peptide and Gelatin Suppliers

• Darling Ingredients Inc.
• GELITA AG
• Nitta Gelatin Inc.
• PB Leiner
• Lapi Gelatine S.p.A.

Nutrition, Beauty and Medical Formulation Platforms

• Symrise AG
• dsm-firmenich

Recombinant Collagen Platforms

• CollPlant Biotechnologies Ltd.

Collagen Market - Report scope

Coverage field	Report scope
Market breakdown	By form, collagen type, ingredient type, sales channel and region.
Quantitative Units	USD billion.
Market Definition	Commercial collagen ingredients including animal-derived collagen, hydrolyzed peptides, gelatin, native collagen and alternative collagen categories sold into food, supplement, beauty and related applications.
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Countries Covered	30+ countries, including USA, UK, Germany, Japan, South Korea, Australia, and Netherlands.
Key Companies Profiled	Darling Ingredients Inc., GELITA AG, Nitta Gelatin Inc., Symrise AG, dsm-firmenich, PB Leiner, Lapi Gelatine S.p.A., CollPlant Biotechnologies Ltd..
Forecast Period	2026 to 2036.
Approach	Primary and secondary research with market triangulation.

Collagen Market - Research Methodology

Method	Approach
Primary Research	Primary research includes interviews with collagen manufacturers, distributors, technology developers, product formulators, end users, and industry experts. The interviews covered product demand, application, pricing, adoption barriers, claims, supply conditions, and future market expectations.
Desk Research	Desk research includes government publications, regulatory documents, trade data, industry associations, company filings, product information, technical literature, and official company announcements. The information was checked according to publication date, market relevance, and defined report scope.
Market Sizing and Forecasting	Market size and forecast were prepared by combining historical market performance, pricing and volume indicators, segment demand, company participation, country conditions, technology development, supply availability, and regulatory factors. Segment and regional estimates were reconciled with the final market value.
Data Validation	Market estimates were checked with public data, company developments, trade patterns, industry activity, and primary interviews. Products and revenues outside the defined collagen market were excluded, while overlapping revenues and unsupported categories were removed to reduce double counting.

Collagen Market by Segments

Collagen Market segmented by Form:

• Nutraceuticals
• Food and Beverage
• Powder
• Capsules
• Cosmetics and Personal Care
• Tablets and Pills
• Liquid
• Gummies

Collagen Market segmented by Collagen Type:

• Animal-based Collagen
• Type I
• Type III
• Alternative and Recombinant Collagen
• Type II
• Marine Collagen
• Porcine Collagen
• Recombinant Collagen

Collagen Market segmented by Ingredient Type:

• Collagen Hydrolysate Peptides
• Recombinant and Fermentation-derived Collagen
• Gelatin
• Native

Collagen Market segmented by Sales Channel:

• Business-to-Business Sales
• Retail Sales
• Store-based Retail
• Online Retail
• Drugstores and Pharmacies
• Hypermarkets Supermarkets
• Specialty Stores
• Health and Wellness Stores

Collagen Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • France
  • Nordics
  • Benelux
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan and Baltic States
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
  • Rest of South Asia and Pacific
• Middle East and Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union Countries
  • Rest of Middle East and Africa

Research Sources and Bibliography

• [1] International Food Information Council. (2025, July 30). Time to flex: Bridging the protein knowledge-action gap.Link
• [2] German Federal Institute for Risk Assessment. (2026, April 17). Perception of micronutrients in food supplements: population survey.Link
• [3] U.S. Food and Drug Administration. (2025, December 11). Letter to the dietary supplement industry on the DSHEA disclaimer.Link
• [4] BASF SE. (2026, April 9). BASF ushers in a new era of collagen science with precision peptide and bio-identical collagen III.Link
• [5] Food Standards Agency. (2026, June 25). Food supplements guidance.
• [6] Consumer Affairs Agency, Government of Japan. (2026). Consumer Affairs Agency booklet 2026.
• [7] Ministry of Food and Drug Safety, Republic of Korea. (2025, January 7). Health functional food functional ingredient re-evaluation results.
• [8] Therapeutic Goods Administration. (2025, January 31). Collagen (ARTG 477269).
• [9] Netherlands Food and Consumer Product Safety Authority. (2025). Inspection results for claims on collagen food supplements.
• [10] Darling Ingredients Inc. (2025, December 10). Darling Ingredients and Tessenderlo Group sign a definitive agreement to form new company.
• [11] Stierman, B., Couch, C. A., Gahche, J. J., & Mishra, S. (2026, May). Dietary Supplement Use: United States, August 2021-August 2023. National Center for Health Statistics Data Brief No. 561, U.S. Centers for Disease Control and Prevention. Link
• [12] Latini, L., Porta, F., Vitale, N., Vreju, F. A., & Filippucci, E. (2026, August 13). Clinical evidence for low-molecular-weight collagen peptides in tendon and ligament tears: a systematic review with narrative synthesis. Frontiers in Medicine. Link
• [13] Wang, Y., Tan, W., & Hong, J. (2026, February). Advances in recombinant type III collagen. Directory of Open Access Journals. Link
• [14] German Federal Institute for Risk Assessment. (2026, April 17). Food supplements: results of a population survey conducted in 2025. Link

This Report Answers

• How large is the Collagen Market in 2026 and 2036?
• Which collagen segments hold notable shares in the 2026 outlook?
• How do Germany and Japan differ in collagen growth outlooks?
• Which operating conditions currently support collagen use in supplement formats?
• Which notable companies supply collagen ingredients through different application routes?
• What does the Collagen Market report include and exclude from scope?